Hutchin Hill Capital’s Pediatrix Medical MD Stock Holding History

Hutchin Hill Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-14,700	Closed	-$950K	–	647
2016 Q1	$950K	Sell	14,700 -52,100	-78%	-$3.46M	0.03%	438
2015 Q4	$4.79M	Buy	+66,800	New	+$4.94M	0.12%	155
2015 Q3	–	Sell	-12,498	Closed	-$926K	–	686
2015 Q2	$926K	Sell	12,498 -3,302	-21%	-$238K	0.02%	484
2015 Q1	$1.15M	Buy	+15,800	New	+$1.1M	0.03%	421
2014 Q4	–	Sell	-128,537	Closed	-$7.05M	–	643
2014 Q3	$7.05M	Buy	128,537 +65,029	+102%	+$3.69M	0.27%	68
2014 Q2	$3.69M	Buy	63,508 +51,208	+416%	+$3.01M	0.17%	91
2014 Q1	$762K	Sell	12,300 -15,500	-56%	-$902K	0.04%	386
2013 Q4	$1.48M	Buy	+27,800	New	+$1.49M	0.1%	207

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Hutchin Hill Capital's MD Position: Q2 2016 in Review

Hutchin Hill Capital sold out of Pediatrix Medical (MD) in Q2 2016, closing a stake of 14,700 shares — an estimated $950K sold.

Hutchin Hill Capital first reported a position in MD in Q4 2013 and held it in 8 quarters. The position peaked at $7.05M in Q3 2014. 391 funds tracked by Wall St. Rank hold MD as of Q2 2016.

Hutchin Hill Capital reported no remaining Pediatrix Medical position as of Q2 2016 after selling out during the quarter.
Hutchin Hill Capital sold 14,700 Pediatrix Medical shares in Q2 2016, an estimated $950K.
Hutchin Hill Capital first reported a position in Pediatrix Medical in Q4 2013 and held it in 8 quarters.
Hutchin Hill Capital's Pediatrix Medical position peaked at $7.05M in Q3 2014.
391 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2016.

Based on Hutchin Hill Capital's 13F filing for Q2 2016, filed 15 Aug 2016.